These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35876022)

  • 1. Sodium-glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease.
    Kato S; Horita N; Utsunomiya D
    ESC Heart Fail; 2022 Oct; 9(5):3661-3662. PubMed ID: 35876022
    [No Abstract]   [Full Text] [Related]  

  • 2. Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.
    Cheng JWM; Colucci V; Kalus JS; Spinler SA
    Ann Pharmacother; 2021 Feb; 55(2):252-260. PubMed ID: 32536199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and renal effects of sodium-glucose co-transporter 2 inhibitors.
    Karagkounis D
    Drug Ther Bull; 2023 Jul; 61(7):103-107. PubMed ID: 37380347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT2 inhibitors in people with and without T2DM.
    Khunti K
    Nat Rev Endocrinol; 2021 Feb; 17(2):75-76. PubMed ID: 33293703
    [No Abstract]   [Full Text] [Related]  

  • 5. SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists.
    Jaswaney R; Sokoloff S; Rakita V; Rubin DJ
    Cleve Clin J Med; 2024 Jul; 91(7):415-423. PubMed ID: 38950981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties.
    Li HY
    J Diabetes Investig; 2021 Mar; 12(3):310-312. PubMed ID: 32967051
    [No Abstract]   [Full Text] [Related]  

  • 7. SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
    Kristensen SL; Jensen J; Schou M
    J Am Coll Cardiol; 2023 May; 81(19):1915-1917. PubMed ID: 37164524
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials.
    Tsai WC; Hsu SP; Chiu YL; Yang JY; Pai MF; Ko MJ; Tu YK; Hung KY; Chien KL; Peng YS; Wu HY
    BMJ Open; 2022 Oct; 12(10):e060655. PubMed ID: 36241355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
    Qiu M; Ding LL; Zhan ZL; Zhou HR
    Eur J Intern Med; 2021 May; 87():98-99. PubMed ID: 33485738
    [No Abstract]   [Full Text] [Related]  

  • 10. When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney Disease.
    O'Meara E; Verma S
    Can J Cardiol; 2021 Apr; 37(4):669-673. PubMed ID: 33450364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and diabetes status do not affect efficacy of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction.
    Patoulias D; Papadopoulos C; Doumas M
    Eur J Intern Med; 2021 May; 87():100-101. PubMed ID: 33632595
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys.
    Lioudaki E; Joslin JR; Trachanatzi E; Androulakis E
    Rev Cardiovasc Med; 2022 Mar; 23(3):82. PubMed ID: 35345249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding the sweet spot in managing diabetes with coronary artery disease and chronic kidney disease: Pharmacotherapy pearls with a focus on sodium-glucose cotransporter-2 inhibitors.
    Trischuk T; Laubscher T; Regier L
    Can Fam Physician; 2020 May; 66(5):341-346. PubMed ID: 32404456
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.
    Hallow KM; Greasley PJ; Helmlinger G; Chu L; Heerspink HJ; Boulton DW
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1295-F1306. PubMed ID: 30019930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
    Salah HM; Al'Aref SJ; Khan MS; Al-Hawwas M; Vallurupalli S; Mehta JL; Mounsey JP; Greene SJ; McGuire DK; Lopes RD; Fudim M
    Am Heart J; 2021 Feb; 232():10-22. PubMed ID: 33214130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.
    Mima A
    Adv Ther; 2021 May; 38(5):2201-2212. PubMed ID: 33860925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-glucose cotransporter-2 inhibitors: Use in patients with chronic kidney disease.
    Falk J; Klarenbach S; Lam C; Potter J
    Can Fam Physician; 2022 Oct; 68(10):753. PubMed ID: 36241403
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on 'Sodium-glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease'.
    Kawada T
    J Hypertens; 2022 Mar; 40(3):624. PubMed ID: 35103629
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
    Jhund PS; Solomon SD; Docherty KF; Heerspink HJL; Anand IS; Böhm M; Chopra V; de Boer RA; Desai AS; Ge J; Kitakaze M; Merkley B; O'Meara E; Shou M; Tereshchenko S; Verma S; Vinh PN; Inzucchi SE; Køber L; Kosiborod MN; Martinez FA; Ponikowski P; Sabatine MS; Bengtsson O; Langkilde AM; Sjöstrand M; McMurray JJV
    Circulation; 2021 Jan; 143(4):298-309. PubMed ID: 33040613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAPA-CKD: Significant Victory for CKD with or without Diabetes.
    Patel AB; Mistry K; Verma A
    Trends Endocrinol Metab; 2021 Jun; 32(6):335-337. PubMed ID: 33676827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.